Elan (ELN) implied volatility Elevated into Phase 3 for Alzheimer's
Tweet Send to a Friend
Elan (NYSE: ELN) : ELN, a neuroscience-based biotechnology company, is recently at $18.40 in pre-open ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


